Welcome to the investor relations center of Accelerate Diagnostics, Inc. Here you will find a wealth of information regarding the company’s performance to date, recent filings, and our strategy for the continued growth of our business.
Accelerate Diagnostics, Inc. is an in-vitro diagnostics company dedicated to providing solutions for the global challenge of antibiotic resistance and hospital acquired infections. Our focus is developing and commercializing innovative instrumentation for the rapid identification and antibiotic susceptibility testing of infectious pathogens.
If you have questions or comments please contact our Investor Relations team by clicking here. We will be happy to help!
Feb 15, 2018
Accelerate Diagnostics reports Q4 and Full-Year Financial Results for 2017
Feb 8, 2018
Accelerate Diagnostics to Host Q4 and Full-Year 2017 Earnings Call on February 15, 2018
Jan 10, 2018
Accelerate Diagnostics achieves CE-IVD milestone for severe bacterial pneumonia assay, doubles revenue for 2017 in Q4